Analysis of the prevalence of antibiotic-resistant opportunistic microflora isolated in patients with bronchitis
Vol 90 No 1 (2021), Infectious and Parasitic Diseases
Vol 90 No 1 (2021)

Analysis of the prevalence of antibiotic-resistant opportunistic microflora isolated in patients with bronchitis

Infectious and Parasitic Diseases
https://doi.org/10.35339/ekm.2021.90.1.k-n
Published March 31, 2021
N.I. Kovalenko
Kharkiv National Medical University, Kharkiv, Ukraine
https://orcid.org/0000-0001-7838-7880
I.V. Novikova
CNPE KhRC "Regional Clinical Hospital", Kharkiv, Ukraine
https://orcid.org/0000-0002-8830-0854
PDF (Українська)

Keywords

antibiotics resistance
opportunistic microorganisms
bronchitis

How to Cite

Kovalenko, N., & Novikova , I. (2021). Analysis of the prevalence of antibiotic-resistant opportunistic microflora isolated in patients with bronchitis. Experimental and Clinical Medicine, 90(1), 21-26. https://doi.org/10.35339/ekm.2021.90.1.k-n
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The study of Staphylococcus and Streptococcus antibiotics sensitivity revealed absolute sensitivity of S. aureus to cefepime and imipenem, S. pyogenes – to amoxiclav, ofloxacin and clindamycin. Staphylococcus showed the greatest resistance to penicillins (50–75%), amoxiclav (35–43%), norfloxacin (40–50%), azithromycin (S. aureus – 14%, S. epidermidis – 84%). Amoxiclav was the most active against Streptococcus (81–100% of sensitive strains). S. pyogenes strains had the greatest resistance to azithromycin (75%), penicillins (50–60%), carbapenems (50–60%). Other Streptococcus were resistant to azithromycin (34–50% cases).

Keywords: antibiotics resistance, opportunistic microorganisms, bronchitis.

https://doi.org/10.35339/ekm.2021.90.1.k-n
PDF (Українська)

References

Alekseenko SN, Drobot EV. Profilaktika zabolevanii: uchebnoe posobie. [Disease prevention: a tutorial]. M.: Izd. dom Akademiya yestestvoznaniya, 2015. 449 p. Available from: https://monographies.ru/ru/book/view?id=524 [in Russian].

Ignatova GL, Belevsky AS. Vazhnyye osobennosti lecheniia ostrogo bronkhita [Important features of the treatment of acute bronchitis]. Prakt. pulmonologiya [Pract. Pulmonology], 2016;2:80-4. Available from: https://is.gd/hB9TE2 [in Russian].

Kolosova NG, Dronov IA. Topicheskaia ingalyatsionnaia antibakterialnaia terapiia respiratornykh infektsiy u detey [Topical inhalation antibiotic therapy of respiratory infections in children]. RMZH. [RMJ], 2017;25(5):219-321 [in Russian].

Santacroce L, Charitos IA, Ballini A, Inchingolo F, Luperto P, De Nitto E, et al. The Human Respiratory System and its Microbiome at a Glimpse. Biology, 2020;9(10):318. DOI: 10.3390/biology9100318. PMID: 33019595. PMCID: PMC7599718.

Kraus EM, Pelzl S, Szecsenyi J, Laux G. Antibiotic prescribing for acute lower respiratory tract infections (LRTI) – guideline adherence in the German primary care setting: An analysis of routine data. PLoS One, 2017;12(3):e0174584. DOI: 10.1371/journal.pone.0174584. PMID: 28350820. PMCID: PMC5370139.

Sinopalnikov AI. Antibiotiki i vnebolnichnye infekcii nizhnih dyhatelnyh putej. Komu? Kakoj? [Antibiotics and community-acquired lower respiratory tract infections. To whom? Which?] Farmateka [Pharmateca], 2019;26(5):47-60. DOI: 10.18565/pharmateca.2019.5.47-60 [in Russian].

Leshchenko IV. Ostryj bronhit: sovremennye problemy diagnostiki i lecheniya [Acute bronchitis: challenges of diagnosis and treatment]. Meditsinskiy sovet [Medical Council], 2013;(3):25-8. DOI: 10.21518/2079-701X-2013-3-25-28 [in Russian].

Dzyublik YaO. Nehospitalni infektsii nyzhnikh dykhalnykh shliakhiv [Non-hospital infections of the lower airways]. Vinnytsia: TOV «MerkiuriPodillia», 2016. 255 p. [In Ukrainian].

Nan D, Jialin D, Chenwei H, Haixia L. Microbial Distribution and Antibiotic Susceptibility of Lower Respiratory Tract Infections Patients From Pediatric Ward, Adult Respiratory Ward, and Respiratory Intensive Care Unit. Front Microbiol, 2020;11:1480. DOI: 10.3389/fmicb.2020.01480. PMID: 32695092. PMCID: PMC7338583.

Harbarth S, Balkhy HH, Goossens H, Jarlier V, Kluytmans J, Laxminarayan R, et al. Antimicrobial resistance: one world, one fight! Antimicrob Resist Infect Control, 2015;4:49. DOI: 10.1186/s13756-015-0091-2.

McCullogh AR, Pollack AL, Hansen MP, Glasziou РP, Looke DF, Britt HC, et al. Antibiotics for acute infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust, 2017;207(2):65-9. DOI: 10.5694/mja16.01042. PMID: 28701117.

Wang J, Xu H, Liu P, Li M. Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis. Int J Chron Obstruct Pulmon Dis. 2017;9(12):2391-405. DOI: 10.2147/COPD.S139521. PMID: 28848340. PMCID: PMC5557110.

Liapikou A, Torres A. The clinical management of lower respiratory tract infections. Exp Rev Respir Med, 2016;10(4):441-52. DOI: 10.1586/17476348.2016.1156537. PMID: 26894943.

Nakaz MOZ Ukrainy No.167 vid 05.04.2007 "Pro zatverdzhennia metodychnykh vkazivok "Vyznachennia chutlyvosti mikroorhanizmiv do antybakterialnykh preparativ" [Order of the Ministry of Health of Ukraine No.167 dated 05 Apr 2007 "About the statement of methodical instructions "Determination of sensitivity of microorganisms to antibacterial drugs"], losing honor 03 Nov 2021. Verkhovna Rada of Ukraine. Legislation of Ukraine [official website]. Available from: https://zakon.rada.gov.ua/rada/show/v0167282-07 [In Ukrainian].

Kovalenko NI, Zamazii NM, Novikova IV, Taranenko GP. Etiological structure and ecological significance of opportunistic pathogens in bronchitis. World of Medicine and Biology, 2020;4(74):68-72. DOI: 10.26724/2079-8334-2020-4-74-68-72.